TASC Industries (India) Ltd. was incorporated on 16th April 1992 as a
Public Limited Company under the Companies Act 1956 at Bombay in the
state of Maharshtra. The certificate of commencement of business was
obtained on 5th June 1992.
The company has been promoted by Mr. Vijay Thakkar, Mr. Sanjay
Thakkar and Mr. Sanjay Sahu to set up a plant for manufacture of
Ciprofloxacin, Chloramphenicol and Chloramphenicol Palmoate. The
promoterws have been trading in bulk drugs and formulations for the
past eight years through their associate concern Tasc Chemical India
-Company has changed its name from Tasc Pharmaceuticals Ltd. to
Marksans Pharma Ltd.
- Marksans Pharma Ltd has informed that the Board of Directors of the
Company at its meeting held on October 30, 2006 has appointed Mr V
Nagaraj as Additional as well as Whole Time Director (marketing) of
-Marksans Pharma Limited has appoineted Mr. V. Nagaraj as Additional
as well as Whole Time Director (marketing) of the Company.
- The Company has splits its face value from Rs10/- to Rs1/-.
-Registered Office of the Company has been shifted From 601-622,
Chintamani Plaza, Mohan Studio Compound, Andheri-Kurla Road, Andheri
(E), Mumbai 400 099 To 21st Floor, Lotus Business Park, Off New Link
Road, Andheri (W), Mumbai 400 0530.
-Marksans Pharma Limited announces USFDA approval of generic
Ibuprofen Capsules (Liquid Filled), 200 mg for Advil Liqui - Gels 200
-Company has entered into a Business Transfer Agreement with Kores
-Registered Office of the Company has been shifted From 21st Floor,
Lotus Business park, Off New Link Road, Andheri (W), Mumbai - 400053
To 11th Floor, Lotus Business Park, Off New Link Road, Andheri (W),
Mumbai - 400053.
-Dr. Balwant Shankarrao Desai has been appointed as a Whole-time
Director of the Company
- Mr. Ajay S. Joshi has been appointed as a Director of the Company
-Marksans Pharma Ltd has appointed Mr. Naresh Balwant Wadhwa as an
additional Director of the Company. Mr. Wadhwa will be an independent
-Marksans Pharma Ltd has recommended dividend of 10% which is Rs.
0.10 per equity share of Rs. 1/- each face value.